Description

Imidazo[1,2-C]Pyrimidine-7-Carboxamide, n-(1S,2R,4R)-7- is a high-purity, stereochemically defined heterocyclic building block of significant interest in advanced organic synthesis. This compound matters as a key chiral intermediate for the research and development of novel pharmaceutical agents, particularly in the areas of antiviral and oncology therapeutics. It is primarily needed by R&D chemists and process development scientists in the pharmaceutical, biotechnology, and fine chemical industries seeking to construct complex molecular architectures with high enantiomeric purity.

Application

• Pharmaceutical Intermediate: Critical chiral scaffold in the synthesis of investigational new drugs (INDs) and active pharmaceutical ingredients (APIs).
• Antiviral Drug Research: Serves as a core structural motif for developing novel antiviral compounds targeting specific viral enzymes.
• Oncology Therapeutics: Used in the construction of small-molecule inhibitors for cancer treatment pathways.
• Chemical Biology & Proteomics: Employed as a specialized building block for creating chemical probes and tool compounds to study biological systems.
• Asymmetric Synthesis: Utilized in stereoselective reactions to introduce complex chirality into target molecules.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting drug discovery and development projects for global clients.

Basic Information

Product Name	Imidazo[1,2-C]Pyrimidine-7-Carboxamide, n-(1S,2R,4R)-7-
CAS No.	588726-98-1
Molecular Formula	C10H11N5O
Molecular Weight	217.23 g/mol
Synonyms	(1S,2R,4R)-N-(Bicyclo[2.2.1]heptan-2-yl)imidazo[1,2-c]pyrimidine-7-carboxamide; (1S,2R,4R)-N-(2-Norbornanyl)imidazo[1,2-c]pyrimidine-7-carboxamide; Imidazo[1,2-c]pyrimidine-7-carboxamide, N-(1S,2R,4R)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl-; N-((1S,2R,4R)-Bicyclo[2.2.1]hept-2-yl)imidazo[1,2-c]pyrimidine-7-carboxamide; Bicyclo[2.2.1]heptane-2-carboxamide, N-(1S,2R,4R)-1,7,7-trimethyl-, imidazo[1,2-c]pyrimidin-7-yl derivative; 588726-98-1; Chiral Imidazopyrimidine Carboxamide
EINECS	Contact for details

Quality Control

Our Imidazo[1,2-C]Pyrimidine-7-Carboxamide, n-(1S,2R,4R)-7- is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including chiral HPLC for enantiomeric excess (ee) verification, NMR for structural confirmation, and stringent purity assays. Certificates of Analysis (COA) detailing identity, purity, chiral purity, and impurity profiles are provided to ensure compliance with your research and development specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound is light-sensitive; prolonged exposure to light should be avoided to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% ee
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.